Search all trials

Find therapies in clinical trials near you – page 3

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Psoriasis

Not recruiting

Registered drug

Comparison of zasocitinib and deucravacitinib in adults with moderate to severe plaque psoriasis

Registered drug

Bulgaria

Participants:18–64 years · 65+ years
Substances:Deucravacitinib

Contact Research Centre

Psoriasis

Not recruiting

Registered drug

Study of zasocitinib (TAK-279) and apremilast compared to placebo in adults with moderate to severe plaque psoriasis

Registered drug

Bulgaria

Participants:18–64 years · 65+ years
Substances:Apremilast

Contact Research Centre

Influenza

Not recruiting

Registered drugNo placebo

Study on the Effectiveness of an MF59-Adjuvanted Influenza Vaccine Compared to a Non-Adjuvanted Vaccine in Adults Aged 65 and Older

Registered drugNo placebo

Bulgaria

Participants:65+ years · Healthy volunteers
Substances:A/DARWIN/9/2021 (H3N2) - LIKE STRAIN (A/DARWIN/6/2021, IVR-227)

Contact Research Centre

Psoriasis

Not recruiting

Investigational

Study on Long-term Safety and Effectiveness of ESK-001 for Patients with Moderate to Severe Plaque Psoriasis

Investigational

Bulgaria

Participants:18–64 years · 65+ years
Substances:Envudeucitinib

Contact Research Centre

Psoriasis

Not recruiting

InvestigationalNo placebo

Study on Long-term Safety and Effectiveness of Zasocitinib for Patients with Moderate-to-Severe Plaque Psoriasis

InvestigationalNo placebo

Bulgaria

Participants:18–64 years · 65+ years
Substances:Zasocitinib

Contact Research Centre

Psoriasis

Not recruiting

Registered drug

Study on the Effectiveness and Safety of ESK-001 and Apremilast for Adults with Moderate to Severe Plaque Psoriasis

Registered drug

Bulgaria

Participants:18–64 years · 65+ years
Substances:Apremilast

Contact Research Centre

Chronic obstructive pulmonary disease

Not recruiting

Investigational

Study on the Effectiveness and Safety of Tanimilast for Patients with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis

Investigational

Bulgaria

Participants:18–64 years · 65+ years
Substances:Tanimilast

Contact Research Centre

Chronic obstructive pulmonary disease

Not recruiting

Investigational

Study on the Effectiveness and Safety of CHF6001 DPI with Roflumilast for Patients with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis

Investigational

Bulgaria

Participants:18–64 years · 65+ years
Substances:Roflumilast

Contact Research Centre

Familial hypertriglyceridaemia+1

Not recruiting

Investigational

Study of Olezarsen (ISIS 678354) in Patients with Severe Hypertriglyceridemia: Testing Effects on Triglyceride Levels

Investigational

Bulgaria

Participants:18–64 years · 65+ years
Substances:Isis 678354 Sodium Salt

Contact Research Centre

Chronic obstructive pulmonary disease

Not recruiting

Investigational

Study on the Effectiveness and Safety of CHF 5993 Compared to CHF 1535 for Patients with Chronic Obstructive Pulmonary Disease (COPD)

Investigational

Bulgaria

Participants:18–64 years · 65+ years
Substances:Beclometasone Dipropionate Anhydrous

Contact Research Centre

Dermatitis atopic

Not recruiting

Registered drug

Study on Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis

Registered drug

Bulgaria

Participants:0–17 years · 18–64 years · 65+ years
Substances:Amlitelimab

Contact Research Centre

Asthma

Not recruiting

Investigational

Study on the Effectiveness and Safety of Tanimilast for Patients with Uncontrolled Asthma on Inhaled Corticosteroid and Long-Acting Beta2-Agonist Therapy

Investigational

Bulgaria

Participants:18–64 years · 65+ years
Substances:Tanimilast

Contact Research Centre

Find therapies in clinical trials near you – page 3

64 trials match your criteria

Psoriasis

Comparison of zasocitinib and deucravacitinib in adults with moderate to severe plaque psoriasis

Psoriasis

Study of zasocitinib (TAK-279) and apremilast compared to placebo in adults with moderate to severe plaque psoriasis

Influenza

Study on the Effectiveness of an MF59-Adjuvanted Influenza Vaccine Compared to a Non-Adjuvanted Vaccine in Adults Aged 65 and Older

Psoriasis

Study on Long-term Safety and Effectiveness of ESK-001 for Patients with Moderate to Severe Plaque Psoriasis

Psoriasis

Study on Long-term Safety and Effectiveness of Zasocitinib for Patients with Moderate-to-Severe Plaque Psoriasis

Psoriasis

Study on the Effectiveness and Safety of ESK-001 and Apremilast for Adults with Moderate to Severe Plaque Psoriasis

Chronic obstructive pulmonary disease

Study on the Effectiveness and Safety of Tanimilast for Patients with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis

Chronic obstructive pulmonary disease

Study on the Effectiveness and Safety of CHF6001 DPI with Roflumilast for Patients with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis

Familial hypertriglyceridaemia+1

Study of Olezarsen (ISIS 678354) in Patients with Severe Hypertriglyceridemia: Testing Effects on Triglyceride Levels

Chronic obstructive pulmonary disease

Study on the Effectiveness and Safety of CHF 5993 Compared to CHF 1535 for Patients with Chronic Obstructive Pulmonary Disease (COPD)

Dermatitis atopic

Study on Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis

Asthma

Study on the Effectiveness and Safety of Tanimilast for Patients with Uncontrolled Asthma on Inhaled Corticosteroid and Long-Acting Beta2-Agonist Therapy

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.